Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readinessSTOCKHOLM, Sweden, 30 September 2026 – AnaCardio, a clinical-stage biopharmaceutical company developing novel therapies for heart failure, today announced the successful completion of a €62.5 million Series B financing. The round was co-led by Novo Holdings and the Ljungström family office, with participation from the originator Helsinn, existing investors Pureos Bioventures, Sound Bioventures, Industrifonden, Flerie and LLD Nybohov Invest AB, alongside new investor Innovestor Life Science.
- Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLCHims & Hers Health (HIMS) Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
- The Rosen Law Firm PAROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline.SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...
- Memorial Healthcare SystemJoe DiMaggio Children's Hospital Foundation receives $230,000 Grant to Expand Pediatric Behavioral Health and Suicide Prevention ServicesThree-year grant from Simply Healthcare Foundation will connect children and families with timely, community-based mental health support — Joe DiMaggio Children's Hospital Foundation has received a $230,000 grant from Simply Healthcare...
- Byron Medical Announces the Product Release of ZUMAX Surgical Microscopes: Setting a New Standard of Advanced Precision DentistryByron Medical Expands Surgical Portfolio with ZUMAX Microscopes - Bringing Advanced Optics, Ergonomic Design and Exceptional Value to Dental Professionals.
- Inland Empire Health Plan (IEHP)IEHP CELEBRA 30 AÑOS DE «CARING TOGETHER»RANCHO CUCAMONGA, California, 29 de septiembre de 2026 -- Coincidiendo con el Día Mundial del Corazón, Inland Empire Health Plan (IEHP) rinde homenaje a tres décadas de asistencia sanitaria con el corazón al anunciar «30 años, cuidando juntos », una campaña...
- ASICSASICS Issues World's First Conservation Warning for Movement as New Research Reveals We're Moving LessSigourney Weaver narrates Human Nature, a new nature documentary from ASICS, exploring how our modern-day habitats are changing the way we move. — Ahead of World Mental Health Day, ASICS is issuing a conservation warning for movement, as new...
- DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 YearsChâtillon, France, September 29, 2026
- Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & EndocrinologyPress release – No. 18 / 2026
- Gain Therapeutics, Inc.Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement DisordersGain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced a poster presentation at the International Congress of Parkinson’s Disease and Movement Disorders, being held October 4-8, 2026, in Seoul, Korea.
- RIDGEWAY PHARMACY DATA BREACH: Edelson Lechtzin LLP Launches Investigation Into Exposure of Health and Payment Card InformationEdelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the Ridgeway Pharmacy, Ltd. data breach
- Altrova Health Inc.Altrova Health Closes Debt SettlementAltrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce that it has closed a debt settlement involving the issuance of common shares in settlement of C$215,000 of bona fide indebtedness (the "Debt Settlement"). All dollar amounts in this news release are expressed in Canadian dollars unless otherwise indicated.The Debt Settlement did not result in any cash proceeds to the...